Table 4: Differentially expressed mRNA targets for the four identified miRNAs.

miRNA 10b 328 193b 193b 628 Drug MG-132 (26S Proteasome inhibitor) Geldanamycin (HSP90 inhibitor) AZ628 (RAF inhibitor) MK-0457 (Aurora kinase inhibitor) PF-2341066 (MET, ALK inhibitor) Targets SMARCC1 SLC16A1 PHF15 EIF2S1 DCTD MKRN2 ANGEL1 RPP30 ARIH2 NUP188 CMTM6 UBR5 RRP1B TMEM231 ELAC1 CSDE1 SEMA3C EIF4B GABBR1 DACT1 MAP4 MEIS2 WDR48 IKZF1 CYP7B1 MYO10 TRIM32 PTPN21 FKTN RPA4 NKTR GM2A CLEC2D GPATCH8 GAR1 RYBP EIF2S1 MRPS16 EZH1 UCKL1 ZNF532 RAC2 NUDT15 OLFML2A IL7 SENP5 OLFML2A NECAP2 PSME3 ABCE1 CBL HIP1 AGTPBP1 CASP3 WHSC1 PRKD3 NMT2 WBP4 FOXJ2 VDR ADARB1 KLF9 APOLD1 YME1L1 GREB1 ACTN2 PEA15 TP63 SMC5 GPM6A RAD1 TFAP2C CCDC28A LSM12 CDC6 CHP2 RNMT PRKCA UBE2K STK24 C15orf29 ADAT1 BNIP2 GPR126 RRP1B PBRM1 PARD6B SERTAD2 AGPAT4 SP2 FGD6 DSC2 UBA52 TRAIP MMP14 PTGIS GOSR1 MAGOHB OLFML2A RAB22A PRKD3 GNL3L FBXW2 SYF2 CTDSPL HS2ST1 SSX2IP MME RPP30 ANKH PPFIBP1 SLC16A3 ZBTB39 M6PR MAN1A2 KBTBD11 KPNA6 TGIF2 SEC16A RMI1 CLEC2D PHC3 RBM15B ZNF510 SS18L2 RTF1 CYLD WDR48 BTRC CCNT2 RAB36